Biotech

All Articles

Zephyrm looks for Hong Kong IPO to fund stage 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submission (PDF) for an ...

Frazier Lifestyle Sciences gathers $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced a further $630 thousand for its own fund paid atte...

GigaGen garners around $135M BARDA dollars to beat botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its...

GPCR company Septerna declare IPO on stamina of preclinical information

.Septerna will figure out how a biotech without "any sort of meaningful professional records" fares ...

Kurma finalizes initially $154M loot for most significant biotech fund yet

.International VC company Kurma Allies has introduced its newest biotech fund, along with 140 millio...

Prothena markets one exec while one more places-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Editas exploit Vertex Cas9 licensing rights for $57M

.Versus the background of a Cas9 license struggle that declines to perish, Editas Medication is actu...

Ultragenyx tweaks genetics treatment dosing to call up efficiency

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson health condition gene therapy UX70...

Biopharma unemployment price stabilizes in Q3: Tough Biotech analysis

.As summertime heat counts on cool down winds, really hopes that this year would deliver prevalent i...

J &amp J falls period 2 dengue prospect in most current change coming from vaccines

.Johnson &amp Johnson's deprioritization of its infectious condition pipe has asserted yet another v...